Catalyst Wire Dossier Catalyst Wire Dossier

LANLUMA V

· Sinclair Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LANLUMA V, covering 2024-04-30 to 2024-04-30. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit [NA]

See pricing